Facial Soft Tissue Augmentation using Autologous Fat Mixed with Stromal Vascular Fraction

Abstract

BackgroundAutologous fat grafting evolved over the twentieth century to become a quick, safe, and reliable method for restoring volume. However, autologous fat grafts have some problems including uncertain viability of the grafted fat and a low rate of graft survival. To overcome the problems associated with autologous fat grafts, we used uncultured adipose tissue-derived stromal cell (stromal vascular fraction, SVF) assisted autologous fat grafting. Thus, the purpose of this study was to evaluate the effect of SVF in a clinical trial.MethodsSVF cells were freshly isolated from half of the aspirated fat and were used in combination with the other half of the aspirated fat during the procedure. Between March 2007 and February 2008, a total of 9 SVF-assisted fat grafts were performed in 9 patients. The patients were followed for 12 weeks after treatment. Data collected at each follow-up visit included clinical examination of the graft site(s), photographs for historical comparison, and information from a patient questionnaire that measured the outcomes from the patient perspective. The photographs were evaluated by medical professionals.ResultsScores of the left facial area grafted with adipose tissue mixed with SVF cells were significantly higher compared with those of the right facial area grafted with adipose tissue without SVF cells. There was no significant adverse effect.ConclusionsThe subjective patient satisfaction survey and surgeon survey showed that SVF-assisted fat grafting was a surgical procedure with superior results.

Concise Review: A Safety Assessment of Adipose-Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events

“…Almost all organ system have been implicated in adipose‐derived cell therapy. The indication for treatment in the included studies was (in order count) soft tissue , gastrointestinal , musculoskeletal , rheumatological , ulcer/ischemic limb , urogenital , cardiac , neurological , immunological , pulmonary , and ophthalmological (Fig. A).…”

Implications for human adipose‐derived stem cells in plastic surgery

“…used CAL in 2008 for cosmetic breast augmentation in 40 patients and reported favourable aesthetic outcome with no major complications . Since then, CAL has been used in other studies for breast augmentation as well as for facial lipoatrophy and augmentation during face‐lift and facial contouring surgeries, among other applications (Table ) .…”

Efficacy and Safety of Cell-Assisted Lipotransfer

“…3,6,10,11,[15][16][17][18][19][20][21][22][23][24][25][26][27] For the recipient sites, eight studies focused on the face, seven studies focused on the Plastic and Reconstructive Surgery • January 2016 breast, one study involved with multiple sites, 3 and one study used the upper arm to perform a clinical trial. 22 Cell-assisted lipotransfer was the intervention in the experimental group.…”